Appendix-ICD-9 Codes and Medications for Identification of Diabetes, Outcomes And

Appendix-ICD-9 Codes and Medications for Identification of Diabetes, Outcomes And

Appendix-ICD-9 codes and medications for identification of diabetes, outcomes and co-morbidities

Disease or condition / ICD-9 codes for disease or procedure / Description
Diabetes / Type I diabetes / 250.x1, 250.x3 / Type I diabetes (controlled and uncontrolled)
Type II diabetes / 250.x0, 250.x2 / Type II diabetes (controlled and uncontrolled)
362.xx / Diabetic retinopathy
Herpes zoster (‘any’) / 053.x (excepting 053.12 and 0.53.13)
Herpes zoster ophthalmicus / 053.20, 053.21, 053.22, 053.29 / Herpes zoster dermatitis of eyelid, keratoconjunctivitis, iridocyclitis, with other ophthalmic complications
Post-herpetic pain / 053.12, 053.13 / Post-herpetic trigeminal neuralgia, post-herpetic polyneuropathy
Chronic pain / 338.2, 338.92 / Chronic pain
Organ transplantation / V42.x, V58.44, 996.80-996.89, 33.50-33.52, 33.6, 41.94, 50.51-50.59, 52.80-52.86, 55.61-55.69 / Solid organ transplantation or aftercare or complications
HIV / V08 / Asymptomatic human immunodeficiency virus (HIV) infection status
042 / Human immunodeficiency virus (HIV) disease
079.53 / Human immunodeficiency virus type 2 [hiv-2]
795.71 / Nonspecific serologic evidence of human immunodeficiency virus (HIV)
Cancers / 140.0-149.9, 150.0-159.9, 160.0-165.9, 170.0-172.9, 174.0-175.9, 176, 179-189.9, 200.00-208.91, 230.0-234.9, 235.0-238.9, 239 / Neoplasms
Immunodeficiency disorders and autoimmune diseases / 242.00-242.01 / Toxic diffuse goiter (Graves’ disease)
245.2 / Chronic lymphocytic thyroiditis (Hashimoto’s disease)
279.00-279.9 / Disorders involving the immune mechanism
288.00-288.9 / Diseases of white blood cells
340 / Multiple sclerosis
357.0 / Acute infectivepolyneuritis (Guillain Barre Syndrome)
358.00-358.01 / Myasthenia gravis
555.0-555.9 / Regional enteritis
556.0-556.9 / Ulcerative enterocolitis
710.0-710.9 / Diffuse diseases of connective tissue
714.00-714.9 / Rheumatoid arthritis and other inflammatory polyarthropathies
Cardiovascular diseases / 410.0-414.9 / Ischemic heart disease
415.0-417.9 / Diseases of pulmonary circulation
421.0-421.9 / Acute and subacute endocarditis
428.0-428.9 / Heart failure
429.0-429.9 / Ill-defined descriptions and complications of heart disease
Chronic obstructive pulmonary diseases / 490 / Bronchitis not specified as acute or chronic
491.0-491.9 / Chronic bronchitis
492.0-492.8 / Emphysema
493.00-493.92 / Asthma
494.0-494.1 / Bronchiectasis
495.0-495.9 / Extrinsic allergic alveolitis
496 / Chronic airway obstruction not elsewhere classified
Renal diseases / 580.0-580.9 / Acute glomerulonephritis
581.0-581.9 / Nephrotic syndrome
582.0-582.9 / Chronic glomerulonephritis
580.0-580.9 / Acute glomerulonephritis
581.0-581.9 / Nephrotic syndrome
582.0-582.9 / Chronic glomerulonephritis
Hepatic diseases / 070.0-070.9 / Viral hepatitis
570 / Acute and subacute necrosis of liver
571.0-571.9 / Chronic liver disease and cirrhosis
572.0-572.8 / Liver abscess and sequelae of chronic liver disease
573.0-573.9 / Other disorders of liver
Metabolic syndrome / 277.7 / Dysmetabolic syndrome (diagnosis based on the presence of two or more of: obesity, dyslipidemia, insulin resistance, hypertension)

Chronic pain medications following Herpes Zoster

Analgesics / Salycilates
Opioids / Tramadol,oxycodone, morphine, methadone, transdermal fentanyl, transdermal bupremorphine
Tricyclic antidepressants / Amitryptiline, nortriptyline, doxepin, desipramine, maprotiline
Anticonvulsants / Carbamezepine, phenytoin, gabapentin, divalproex, oxvarbazepine, pregabalin, topiramate, duloxetin
Sodium channel blocker / Mexilitine, lidocaine cream, lidoderm, EMLA (lidocaine / prilocaine), prilocaine
Other topical analgesics / Capsaicin
Serotonin-norepinephrine reuptake inhibitor / Venlafaxine, duloxetine

1